Clinical Trial Update: Evaluation of the Response of Itraconazole and Terbinafine Therapy in Subjects With Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating itraconazole and terbinafine for Crohn's disease has been terminated. The update notes the study status but does not provide results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease

Drugs mentioned

• Itraconazole (Itraconazole)
• Terbinafine (terbinafine)

Snippet

Sponsor: Montreal Heart Institute | Conditions: Crohn's Disease, Inflammatory Bowel Diseases | Phase 2 | Status: TERMINATED